期刊文献+

超声压力-应变环技术评价乳腺癌化疗后心肌做功能力的改变 被引量:14

Ultrasonic Pressure-Strain Loops Technique in Evaluating the Changes of Myocardial Function After Breast Cancer Chemotherapy
下载PDF
导出
摘要 目的应用压力-应变环技术(PSL)评价乳腺癌患者使用蒽环类药物后的左心室收缩功能改变,探讨其在评价化疗早期心肌毒性中的应用价值。资料与方法选取经病理确诊的乳腺癌患者35例,左心室射血分数(LVEF)均>55%,所有患者均接受蒽环类药物化疗。分别于化疗前及化疗3个周期后行二维超声心动图检查左心室功能参数,包括左心室舒张末期内径(LVEDd)、左心室舒张期容积(LVEDV)、左心室收缩末期内径(LVEDs)、左心室收缩期容积(LVESV)、LVEF和左心室短轴缩短率(FS),作为化疗前及化疗后组;选取同期健康志愿者20例作为对照组。分析左心室应变及做功参数指标的相关性。结果与对照组比较,化疗前LVEDd、LVEDV、LVEDs、LVESV、LVEF、FS差异均无统计学意义(P>0.05),左心室纵向收缩期峰值应变(GLS)、整体做功指数(GWI)、整体有效功(GCW)、整体无效功(GWW)、整体做功效率(GWE)差异无统计学意义(P>0.05);与乳腺癌化疗前及对照组比较,化疗后LVEDd、LVEDV、LVEDs、LVESV、LVEF、FS差异均无统计学意义(P>0.05),GLS、GWI、GCW及GWE较低,GWW较高,差异有统计学意义(P均<0.05)。GLS与GWI、GCW呈正相关(R^2=0.729、0.777,P<0.01),GLS与GWW、GWE无明显相关性(P>0.01)。结论PSL测得GWI、GCW、GWW、GWE各参数结合GLS分析能较早地发现乳腺癌患者使用蒽环类化疗后的心功能障碍,为早期临床干预提供参考依据。 Purpose To evaluate the left ventricular systolic function changes in breast cancer patients after using anthracyclines by using pressure-strain loops(PSL),and to explore its application value in evaluating early myocardial toxicity of chemotherapy.Materials and Methods Thirty-five patients with pathologically confirmed breast cancer,with left ventricular ejection fraction(LVEF)>55%were selected.All patients received anthracycline chemotherapy.Two-dimensional echocardiography was performed before and after 3 cycles of chemotherapy to obtain left ventricular function parameters,including left ventricular end-diastolic diameter(LVEDd),left ventricular end-diastolic volume(LVEDV),left ventricular end-systolic diameter(LVEDs),left ventricular end-systolic volume(LVESV),LVEF and left ventricular fractional shortening(FS).Twenty healthy volunteers of the same period were selected as the control group.The correlation between left ventricular strain and work parameters was analyzed.Results Compared with the control group,there was no significant difference in LVEDd,LVEDV,LVEDs,LVESV,LVEF and FS before chemotherapy(P>0.05);the left ventricular longitudinal systolic peak strain(GLS),global work index(GWI),overall effective work(GCW),global invalid work(GWW)and overall work efficiency(GWE)were not statistically different(P>0.05);compared with those before breast cancer chemotherapy and the control group,there was no significant difference in LVEDd,LVEDV,LVEDs,LVESV,LVEF and FS after chemotherapy(P>0.05);GLS,GWI,GCW and GWE were low,and GWW was high,with statistical difference(P<0.05).GLS was positively correlated with GWI and GCW(R^2=0.729 and 0.777,P<0.01),GLS showed no significant correlation with GWW and GWE(P>0.01).Conclusion GWI,GCW,GWW and GWE measured by PSL combined with GLS analysis can early detect the heart dysfunction of breast cancer patients after anthracycline chemotherapy,providing a reference for clinical intervention.
作者 柴玉娇 袁建军 朱好辉 姬冰 武中州 李思靓 CHAI Yujiao;YUAN Jianjun;ZHU Haohui;JI Bing;WU Zhongzhou;LI Siliang(Department of Ultrasound,Henan Provincial People's Hospital,Zhengzhou 450003,China;不详)
出处 《中国医学影像学杂志》 CSCD 北大核心 2020年第10期757-760,765,共5页 Chinese Journal of Medical Imaging
关键词 乳腺肿瘤 蒽环类 抗肿瘤药 超声心动描记术 压力-应变环 心室功能 Breast neoplasms Anthracyclines Antineoplastic agents Echocardiography Pressure-strain loops Ventricular function,left
  • 相关文献

参考文献5

二级参考文献52

  • 1礼广森,任卫东,崔洪岩,张卓,夏稻子.心肌背向散射积分参数评价蒽环类抗肿瘤药早期心脏毒性的实验研究[J].中国超声医学杂志,2006,22(3):161-163. 被引量:7
  • 2Teoh H,Després JP,Dufour R,et al.Identification and management of patients at elevated cardiometabolic risk in Canadian primary care:how well are we doing?Can J Cardiol,2013,29(8):960-968.
  • 3Ivanovic BA,Tadic MV,Simic DV.Are all criteria of metabolic syndrome equally harmful?Acta Cardiol,2011,66(2):189-196.
  • 4Karakurt O,Oztekin S,Yaz?han N,et al.Impaired right ventricular functions in metabolic syndrome patients with preserved left ventricular ejection fraction.Turk Kardiyol Dern Ars,2011,39(7):549-556.
  • 5Tadic M,Ivanovic B,Celic V,et al.The impact of metabolic syndrome,recently diagnosed diabetes and hypertension on right ventricular remodeling.Is there difference between risk factors?Clin Exp Hypertens,2014,36(5):295-301.
  • 6Tadic M,Ivanovic B,Celic V,et al.Are the metabolic syndrome,blood pressure pattern,and their interaction responsible for the right ventricular remodeling?Blood Press Monit,2013,18(4):195-202.
  • 7Paneni F,Gregori M,Tocci G,et al.Do diabetes,metabolic syndrome or their association equally affect biventricular function?A tissue Doppler study.Hypertens Res,2013,36(1):36-42.
  • 8Lang RM,Badano LP,Mor-Avi V,et al.Recommendations for cardiac chamber quantification by echocardiography in adults:an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.J Am Soc Echocardiogr,2015,28(1):1-39.e14.
  • 9Tadic M,Ivanovic B,Kostic N,et al.Metabolic syndrome and left ventricular function:is the number of criteria actually important?Med Sci Monit,2012,18(5):CR282-CR289.
  • 10Ertürk M,?ner E,Kalkan AK,et al.The role of isovolumic acceleration in predicting subclinical right and left ventricular systolic dysfunction in patient with metabolic syndrome.Anadolu Kardiyol Derg,2015,15(1):42-49.

共引文献66

同被引文献88

引证文献14

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部